Literature DB >> 17651807

Neurosteroid regulation of central nervous system development.

Synthia H Mellon1.   

Abstract

Neurosteroids are a relatively new class of neuroactive compounds brought to prominence in the past 2 decades. Despite knowing of their presence in the nervous system of various species for over 20 years and knowing of their functions as GABA(A) and N-methyl-d-aspartate (NMDA) ligands, new and unexpected functions of these compounds are continuously being identified. Absence or reduced concentrations of neurosteroids during development and in adults may be associated with neurodevelopmental, psychiatric, or behavioral disorders. Treatment with physiologic or pharmacologic concentrations of these compounds may also promote neurogenesis, neuronal survival, myelination, increased memory, and reduced neurotoxicity. This review highlights what is currently known about the neurodevelopmental functions and mechanisms of action of 4 distinct neurosteroids: pregnenolone, progesterone, allopregnanolone, and dehydroepiandrosterone (DHEA).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17651807      PMCID: PMC2386997          DOI: 10.1016/j.pharmthera.2007.04.011

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  271 in total

1.  The PXR crystal structure: the end of the beginning.

Authors:  Sean Ekins; Erin Schuetz
Journal:  Trends Pharmacol Sci       Date:  2002-02       Impact factor: 14.819

2.  GABA uptake regulates cortical excitability via cell type-specific tonic inhibition.

Authors:  Alexey Semyanov; Matthew C Walker; Dimitri M Kullmann
Journal:  Nat Neurosci       Date:  2003-05       Impact factor: 24.884

3.  The enantiomer of progesterone acts as a molecular neuroprotectant after traumatic brain injury.

Authors:  Jacob W VanLandingham; Sarah M Cutler; Sharad Virmani; Stuart W Hoffman; Douglas F Covey; Kathiresan Krishnan; Stephen R Hammes; Michelle Jamnongjit; Donald G Stein
Journal:  Neuropharmacology       Date:  2006-08-22       Impact factor: 5.250

4.  Immunohistochemical presence of 5 alpha-reductase rat type 1-containing cells in the rat brain.

Authors:  Y Tsuruo; T Miyamoto; H Yokoi; K Kitagawa; S Futaki; K Ishimura
Journal:  Brain Res       Date:  1996-05-25       Impact factor: 3.252

5.  Gamma-aminobutyric acidA receptor complexes in rat frontal cortex and spinal cord show differential responses to steroid modulation.

Authors:  K W Gee; N C Lan
Journal:  Mol Pharmacol       Date:  1991-12       Impact factor: 4.436

Review 6.  Ligand recognition by drug-activated nuclear receptors PXR and CAR: structural, site-directed mutagenesis and molecular modeling studies.

Authors:  Antti Poso; Paavo Honkakoski
Journal:  Mini Rev Med Chem       Date:  2006-08       Impact factor: 3.862

Review 7.  Social isolation stress-induced aggression in mice: a model to study the pharmacology of neurosteroidogenesis.

Authors:  Kinzo Matsumoto; Graziano Pinna; Giuli Puia; Alessandro Guidotti; Erminio Costa
Journal:  Stress       Date:  2005-06       Impact factor: 3.493

8.  Progesterone modulates brain-derived neurotrophic factor and choline acetyltransferase in degenerating Wobbler motoneurons.

Authors:  Maria Claudia Gonzalez Deniselle; Laura Garay; Susana Gonzalez; Flavia Saravia; Florencia Labombarda; Rachida Guennoun; Michael Schumacher; Alejandro F De Nicola
Journal:  Exp Neurol       Date:  2006-10-17       Impact factor: 5.330

Review 9.  Neurosteroidogenesis: relevance to neurosteroid actions in brain and modulation by psychotropic drugs.

Authors:  Maria Luisa Barbaccia
Journal:  Crit Rev Neurobiol       Date:  2004

10.  Pregnenolone and its sulfate ester in the rat brain.

Authors:  C Corpéchot; M Synguelakis; S Talha; M Axelson; J Sjövall; R Vihko; E E Baulieu; P Robel
Journal:  Brain Res       Date:  1983-06-27       Impact factor: 3.252

View more
  56 in total

Review 1.  Malformation syndromes caused by disorders of cholesterol synthesis.

Authors:  Forbes D Porter; Gail E Herman
Journal:  J Lipid Res       Date:  2010-10-07       Impact factor: 5.922

2.  The GABAergic deficit hypothesis of major depressive disorder.

Authors:  B Luscher; Q Shen; N Sahir
Journal:  Mol Psychiatry       Date:  2010-11-16       Impact factor: 15.992

3.  Neurosteroid transport by the organic solute transporter OSTα-OSTβ.

Authors:  Fang Fang; Whitney V Christian; Sadie G Gorman; Mei Cui; Jiaoti Huang; Kim Tieu; Nazzareno Ballatori
Journal:  J Neurochem       Date:  2010-08-12       Impact factor: 5.372

Review 4.  Controversies in preterm brain injury.

Authors:  Anna A Penn; Pierre Gressens; Bobbi Fleiss; Stephen A Back; Vittorio Gallo
Journal:  Neurobiol Dis       Date:  2015-10-23       Impact factor: 5.996

Review 5.  Adverse effects of 5α-reductase inhibitors: What do we know, don't know, and need to know?

Authors:  Abdulmaged M Traish; Roberto Cosimo Melcangi; Marco Bortolato; Luis M Garcia-Segura; Michael Zitzmann
Journal:  Rev Endocr Metab Disord       Date:  2015-09       Impact factor: 6.514

6.  II. Cognitive performance of middle-aged female rats is influenced by capacity to metabolize progesterone in the prefrontal cortex and hippocampus.

Authors:  Jason J Paris; Alicia A Walf; Cheryl A Frye
Journal:  Brain Res       Date:  2010-10-31       Impact factor: 3.252

Review 7.  Neurosteroids and GABAergic signaling in health and disease.

Authors:  Georgina MacKenzie; Jamie Maguire
Journal:  Biomol Concepts       Date:  2013-02

8.  Changes in neuroactive steroid concentrations after preterm delivery in the Guinea pig.

Authors:  Meredith A Kelleher; Jonathan J Hirst; Hannah K Palliser
Journal:  Reprod Sci       Date:  2013-04-12       Impact factor: 3.060

Review 9.  Pregnenolone, dehydroepiandrosterone, and schizophrenia: alterations and clinical trials.

Authors:  Michael S Ritsner
Journal:  CNS Neurosci Ther       Date:  2010       Impact factor: 5.243

Review 10.  The pathogenesis of Niemann-Pick type C disease: a role for autophagy?

Authors:  Chris D Pacheco; Andrew P Lieberman
Journal:  Expert Rev Mol Med       Date:  2008-09-10       Impact factor: 5.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.